Page last updated: 2024-08-23

permethrin and azelaic acid

permethrin has been researched along with azelaic acid in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Gover, MD; Graber, M; Gupta, AK; Hollis, S; van Zuuren, EJ1
Abdel Gawad, EH; Al Mokadem, S; El Harras, MA; Gomaa, SM; Mostafa, FF; Nassar, AA1

Reviews

1 review(s) available for permethrin and azelaic acid

ArticleYear
Systematic review of rosacea treatments.
    Journal of the American Academy of Dermatology, 2007, Volume: 56, Issue:1

    Topics: Administration, Cutaneous; Administration, Oral; Anti-Bacterial Agents; Benzoyl Peroxide; Cosmetics; Dicarboxylic Acids; Diet; Double-Blind Method; Drug Therapy, Combination; Humans; Metronidazole; Omeprazole; Permethrin; Randomized Controlled Trials as Topic; Research Design; Rosacea; Single-Blind Method; Sunscreening Agents; Tetracyclines; Treatment Outcome

2007

Trials

1 trial(s) available for permethrin and azelaic acid

ArticleYear
Comparative study of some treatment modalities of rosacea.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2009, Volume: 23, Issue:1

    Topics: Adult; Dicarboxylic Acids; Double-Blind Method; Female; Humans; Male; Metronidazole; Middle Aged; Permethrin; Rosacea

2009

Other Studies

1 other study(ies) available for permethrin and azelaic acid

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004